Skip to main content
Distal arthrogryposis type 5 and PIEZO2 novel variant in a Canadian family.
American Journal of Medical genetics. Part A
  • Eugenio Zapata-Aldana
  • Sulaiman B Al-Mobarak, Western University
  • Natalya Karp, Western University
  • Craig Campbell, Western University
Document Type
Publication Date
URL with Digital Object Identifier

The group of distal arthrogryposis (DA) disorders is characterized by congenital contractures of the distal joints. In most instances, these are genetic disorders are inherited in an autosomal dominant fashion; however, there is wide genetic and phenotypic spectrum. Distal arthrogryposis type 5 (DA5) is clinically characterized by short stature, deep-set eyes, ptosis, ophthalmoplegia, triangular facies, restrictive pulmonary function, and "firm" muscles. DA5 is produced by a gain-of-function mutations in PIEZO2 gene, encoding for an ion-channel required to convert mechanical stimulus to biological signals in mammals essential to proprioception. Heterozygous mutations in PIEZO2 may lead to other phenotypes like Gordon Syndrome and Marden Walker syndrome. In this report, we present a 3-generation family affected with DA5, who all carry a variant of unknown clinical significance c.8068A>C (p.Ser2690Arg) in the PIEZO2 gene. DA5 is a very rare condition with less than 20 cases previously reported. Our report expands the phenotype and contributes to evidence of this variant's pathogenicity.

Citation Information
Eugenio Zapata-Aldana, Sulaiman B Al-Mobarak, Natalya Karp and Craig Campbell. "Distal arthrogryposis type 5 and PIEZO2 novel variant in a Canadian family." American Journal of Medical genetics. Part A Vol. 179 Iss. 6 (2019) p. 1034 - 1041
Available at: